Book ; Online: Immunotherapy in Hepatocellular Carcinoma
2023
Keywords | Medicine ; Oncology ; cancer immunotherapy ; TCGA ; mutations ; copy number variations ; microRNAs ; PD-1 ; PD-L1 ; hepatocellular carcinoma ; predictive factors ; immunotherapy ; immune checkpoint inhibition ; check-point inhibitors ; liver disease ; outcome ; biomarkers ; combination immunotherapy ; immune-related adverse events (irAEs) ; hepatocellular carcinoma (HCC) ; alpha fetoprotein response ; immune checkpoint inhibitor ; unresectable hepatocellular carcinoma ; a disintegrin and metalloprotease 9 ; nivolumab ; natural killer ; CTLA-4 ; combination therapy ; PD-1 antibody ; PD-L1 antibody ; anti-VEGF inhibitor ; molecular classification ; immune phenotype ; stem cell marker ; oncogenic signal ; β-catenin ; genetic alteration ; liver cancer ; effectiveness ; safety ; HCC ; molecular-targeted agent ; TACE ; tyrosine kinase inhibitor ; CD14+ cells ; programmed death 1 ligands ; translational approaches ; combination therapies ; therapy resistance ; predictive markers ; tissue-resident memory CD8 T cells ; immune checkpoint blockade |
---|---|
Language | English |
Size | 1 electronic resource (276 pages) |
Publisher | MDPI - Multidisciplinary Digital Publishing Institute |
Publishing place | Basel |
Document type | Book ; Online |
Note | English |
HBZ-ID | HT030377297 |
ISBN | 9783036566900 ; 3036566902 |
Database | ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.